Study finds NY-based Regeneron COVID-19 cocktail can save lives of patients hospitalized with virus
The drug combination from Tarrytown-based Regeneron Pharmaceuticals, in New York, cut patient deaths from 30% to 24% among those who hadn’t already developed an immune response against COVID-19.
Share:
